Allyl isothiocyanate exhibits no anticancer activity in MDA-MB-231 breast cancer cells

Md Abu Sayeed, Massimo Bracci, Veronica Ciarapica, Marco Malavolta, Mauro Provinciali, Ernesta Pieragostini, Simona Gaetani, Federica Monaco, Guendalina Lucarini, Venerando Rapisarda, Roberto Di Primio, Lory Santarelli

Research output: Contribution to journalArticle

Abstract

It was reported recently that allyl isothiocyanate (AITC) could inhibit various types of cancer cell growth. In the present study, we further investigated whether AITC could inhibit the growth of human breast cancer cells. Unexpectedly, we found that AITC did not inhibit, rather slightly promoted, the proliferation of MDA-MB-231 breast cancer cells, although it did have inhibitory effect on MCF-7 breast cancer cells. Cytofluorimetric analysis revealed that AITC (10 µM) did not induce apoptosis and cell cycle arrest in MDA-MB-231 cells. In addition, AITC significantly (p < 0.05) increased the expression of BCL-2 and mTOR genes and Beclin-1 protein in MDA-MB-231 cells. No significant changes in expression of PRKAA1 and PER2 genes, Caspase-8, Caspase-9, PARP, p-mTOR, and NF-κB p65 proteins were observed in these AITC-treated cells. Importantly, AITC displayed cytotoxic effect on MCF-10A human breast epithelial cell line. These observations suggest that AITC may not have inhibitory activity in MDA-MB-231 breast cancer cells. This in vitro study warrants more preclinical and clinical studies on the beneficial and harmful effects of AITC in healthy and cancer cells.

Original languageEnglish
Article number145
JournalInternational Journal of Molecular Sciences
Volume19
Issue number1
DOIs
Publication statusPublished - Jan 4 2018

Keywords

  • Allyl isothiocyanate
  • Apoptosis
  • Breast cancer
  • Cell cycle
  • Proliferation

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Fingerprint Dive into the research topics of 'Allyl isothiocyanate exhibits no anticancer activity in MDA-MB-231 breast cancer cells'. Together they form a unique fingerprint.

  • Cite this

    Sayeed, M. A., Bracci, M., Ciarapica, V., Malavolta, M., Provinciali, M., Pieragostini, E., Gaetani, S., Monaco, F., Lucarini, G., Rapisarda, V., Di Primio, R., & Santarelli, L. (2018). Allyl isothiocyanate exhibits no anticancer activity in MDA-MB-231 breast cancer cells. International Journal of Molecular Sciences, 19(1), [145]. https://doi.org/10.3390/ijms19010145